Albrandt SA, Murrieta GH, Aguilar PJL, Barrera FJL, Herrera GA, De la Garza SJ, Mohar BA

Language: Spanish
References: 17
Page: 565-571
PDF size: 404.66 Kb.

ABSTRACT

After treatment of cervical carcinoma; recurrent disease may be observed in multiples sites at imaging studies. Both typical and atypical manifestations of recurrent disease occur. Typical manifestations of recurrent cervical carcinoma involve the pelvis and lymph nodes. Pelvic recurrences may be observed as masses involving the cervix and uterus, vagina or vaginal cuff, parametria, bladder, rectum or ovaries and may be identified as enlarged pelvic and retroperitoneal nodes. Atypical manifestations of recurrent cervical carcinoma are recognized with greater frequency due to the use of intensive pelvic radiation therapy, the evolution of improved imaging techniques and the more frequent use of imaging as a means of surveillance. This atypical manifestations may involve the solid organs of the abdomen (focal masses) as well as the peritoneum, mesentery and ometum (implants); gastrointestinal tract (obstruction, fistulae formation, isquemia); chest (metastases to the lung parenchyma, pleura and pericardium); bones (destructive lesions); and other sites. The knowledge of the image features of recurrent cervical carcinoma in this anatomic locations will facilitate prompt, and accurate diagnosis and treatment.

REFERENCES

1. Registro histopatológico de neoplasias malignas. Compendio de mortalidad/morbilidad/1999. Dirección General de Epidemiología. SSA

2. Goodman A, Hill EC. Premalignant & malignant disorders of the uterine cervix. In DeCherney AH, Pernoll ML (eds.) Curren obstrtetric & gynecologic diagnosis & treatment 8th edition. Norwalk, CT: Appleton & Lange. 1994 pp 921-936.

3. Cannistra SA, Niloff JM. Cancer of the uterine cervix (review). N Engl J Med. 1996;334: 1030-1038.

4. Sotto LS, Graham JB, Pickien JN. Postmortem findings in cancer of the cervix. Am J Obstet Gynecol. 1990;80:791-794.

5. Kavanagh BD, Greschen HL, Schidt URK. A pilot study of concomitant boost accelerated super fractionated radiotherapy for stage III cancer of the cervix. Int J Radiat Oncol Bio Phys. 1997;38:561-568.

6. Badilo AO, Kurohara SS, Webster JH. Metastasis to organs in carcinoma of the uterine cervix. Cancer 1988;21:434-439.

7. Henrikesen E. The lymphatic spread of carcinoma of the cervix and of the body of the uterus. Am J Obstet Gynecol. 1989;58:924-942.

8. Henrikesen E. The dispersion of caner of the cervix. Radiology 1990. 54;812-815.

9. Carlson V, Delchos L, Fletcher G. Distan metastases in squamus cell carcinoma of the uterine cervix. Radiology 1967; 88: 961-966.

10. Pearson B, Garcia M. Spread and metastasis in carcinoma of the cervix uteri: their significance in planning treatment. New Orleans Med J 1992; 195:215-219.

11. Drescher CW, Hopkins MP, Roberts JA. Comparison of the pattern of metastasic spread squamus cell carcinoma and adenocarcinoma in the uterine cervix. Gynecol Oncol 1989;33:340-343.

12. Warren S. Distribution of metastases in carcinoma of the cervix uteri. Surg Gynecol Obstet 1993;56:742-745.

13. Figge DC, Tamini HK. Patterns of recurrence of carcinoma following radical hysterectomy. Am J Obstet Gynecol 1981;140:213-218.

14. Kinkel A, Ariche M. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced substraction MRI. Radiology 1997;204:55-63.

15. Yamashita Y, Horada M. Dynamic MRI in recurrent postoperatory cervical cancer. JMRI 1996;6:167-171.

16. Flynn VT, Spurret BR. Sister Joseph´s nodule. Med J Aust 1969;1:728-730.

17. Rubesin SE, Schnall MD. Rectum. In: Gore RM ed. Textbook of gastrointestinal radiology. Philadelphia, Pa. Saunders 1994;1261-1309.